PinnyPeptide

Prostamax vs Vesilute

Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.

Peptide A

Prostamax

Bioregulators

Khavinson short peptide bioregulator targeting prostate tissue.

Peptide B

Vesilute

Bioregulators

Khavinson short peptide bioregulator targeting urinary bladder epithelium.

Typical vial

20 mg

Typical dose

1,000-5,000 mcg

Half-life

Short (minutes); biological effect persists via gene-expression modulation

FDA status

Not FDA approved.

Typical vial

20 mg

Typical dose

1,000-5,000 mcg

Half-life

Short (minutes); biological effect persists via gene-expression modulation

FDA status

Not FDA approved.

Prostamax effects

  • Reported improvement in chronic prostatitis symptoms
  • Possible reduction in BPH-related urinary symptoms
  • Anti-inflammatory effects in prostate tissue
  • Modulation of prostate gene expression
  • Russian observational support for elderly male prostate health

Vesilute effects

  • Reported improvement in chronic cystitis symptoms
  • Possible reduction in overactive bladder symptoms
  • Anti-inflammatory effects in bladder tissue
  • Support of bladder epithelial integrity
  • Modulation of bladder gene expression

Prostamax side effects

  • Generally well-tolerated in Russian clinical use
  • Mild injection-site reactions
  • Limited Western safety validation
  • Not a substitute for proper urological evaluation

Vesilute side effects

  • Generally well-tolerated in Russian clinical use
  • Mild injection-site reactions
  • Limited Western safety validation
  • Not a substitute for proper urological evaluation

Prostamax dosing ranges

Prostate health support

1-5 mg · Once daily (SubQ) or sublingual · 10-20 day cycles, repeated 2-3 times per year

Vesilute dosing ranges

Bladder function support

1-5 mg · Once daily (SubQ) or sublingual · 10-20 day cycles, repeated 2-3 times per year

Full Prostamax guide → Full Vesilute guide →

Prostamax vs Vesilute — common questions

What is the difference between Prostamax and Vesilute?

Prostamax: Khavinson short peptide bioregulator targeting prostate tissue. Typical dose 1,000-5,000 mcg. Vesilute: Khavinson short peptide bioregulator targeting urinary bladder epithelium. Typical dose 1,000-5,000 mcg. Both fall under the Bioregulators category.

Can you stack Prostamax and Vesilute?

Stacking Prostamax with Vesilute is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.

Which is dosed more frequently, Prostamax or Vesilute?

Prostamax is typically dosed: Once daily (SubQ) or sublingual for Prostate health support. Vesilute is typically dosed: Once daily (SubQ) or sublingual for Bladder function support.

Are Prostamax and Vesilute FDA approved?

Prostamax: Not FDA approved. Vesilute: Not FDA approved.

Related peptide comparisons

bronchogen vs prostamaxcardiogen vs prostamaxcartalax vs prostamaxcortagen vs prostamaxcrystagen vs prostamaxprostamax vs testagen

Tracking either of these?

Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.

Get Started Free